APAC Employee Medical Plan Costs to Stabilise in 2026 After Two Years of Sharp Increase, Aon reports
- Written by Reporters
- China, India, Singapore, the Philippines and Vietnam projecting lower increases than previous year
- Cardiovascular diseases, gastrointestinal conditions and cancer are top medical conditions that are expected to drive the medical plan costs
- Around one third of APAC markets — including China, Singapore, the Philippines, Vietnam and India — expect a slight decrease in trend rates, driven by moderated utilisation and wellbeing initiatives.
- Prescription and specialty medications, innovations in medical technology and geopolitical factors, continue to have a significant impact.
- The remaining two thirds face upward pressure from chronic disease burden, increased healthcare utilisation and adoption of technological advancements.
2025 | 2026 | |||
Annual General Inflation Rate | Annual Medical Trend Rates(Gross) | Annual General Inflation Rate | Annual Medical Trend Rates (Gross) | |
Asia-Pacific | 2.8 | 11.1 | 2.4 | 11.3 |
Australia | 3.0 | 5.1 | 3.5 | 5.2 |
Bangladesh | 6.1 | 10.0 | 5.2 | 10.0 |
China | 2.0 | 8.0 | 0.6 | 7.8 |
Hong Kong | 2.3 | 8.0 | 2.2 | 9.0 |
India | 4.2 | 13.0 | 4.1 | 11.5 |
Indonesia | 2.6 | 16.2 | 2.5 | 16.9 |
Japan | 2.1 | 0.9 | 1.7 | 2.7 |
Kazakhstan | 7.0 | 29.0 | 9.4 | 29.0 |
Malaysia | 2.5 | 15.0 | 2.2 | 16.0 |
New Zealand | 2.5 | 17.0 | 2.0 | 18.0 |
Pakistan | 12.7 | n/a | 7.7 | 23.5 |
Papua New Guinea | 4.8 | 12.0 | 4.6 | 15.0 |
Philippines | 3.0 | 15.0 | 2.9 | 14.0 |
Singapore | 2.5 | 14.0 | 1.5 | 13.0 |
South Korea | 2.0 | 10.0 | 1.8 | 11.5 |
Sri Lanka | n/a | n/a | n/a | 6.5 |
Taiwan | 1.6 | n/a | 1.6 | 8.0 |
Thailand | 1.2 | 14.3 | 0.9 | 14.8 |
Vietnam | 3.4 | 12.9 | 2.5 | 12.2 |
- Cardiovascular Disease: Disorders of the heart and blood vessels and high blood pressure continue to be the primary cost driver, with the greatest impact on claims across APAC.
- Gastrointestinal Conditions: Issues such as gallbladder stones, infections, acute appendicitis, liver diseases and gastroenteritis are rising and now the second most common cost driver in the region.
- Cancer/Tumor Growth: Cancer remains a top condition globally, with 20 countries –including Australia and Singapore – reporting it as the most impactful. The most frequently diagnosed cancers are lung, breast, colon/rectum, and prostate.
The issuer is solely responsible for the content of this announcement.
About Aon
Aon plc (NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that protect and grow their businesses. Follow Aon on LinkedIn, X, Facebook and Instagram. Stay up-to-date by visiting Aon's newsroom and sign up for news alerts here. DisclaimerThe information contained in this document is solely for information purposes, for general guidance only and is not intended to address the circumstances of any particular individual or entity. Although Aon endeavours to provide accurate and timely information and uses sources that it considers reliable, the firm does not warrant, represent or guarantee the accuracy, adequacy, completeness or fitness for any purpose of any content of this document and can accept no liability for any loss incurred in any way by any person who may rely on it. There can be no guarantee that the information contained in this document will remain accurate as on the date it is received or that it will continue to be accurate in the future. No individual or entity should make decisions or act based solely on the information contained herein without appropriate professional advice and targeted research
Source https://www.media-outreach.com/news/singapore/2025/10/15/418952/